News | Radiopharmaceuticals and Tracers | April 11, 2017

New company will provide diagnostic and therapeutic solutions from 21 manufacturing centers worldwide

IBA Molecular and Mallinckrodt Nuclear Medicine Merge to Become Curium

April 11, 2017 — IBA Molecular announced that it has merged with previous acquisition Mallinckrodt Nuclear Medicine LLC to form the new company Curium.

The new entity delivers diagnostic and therapeutic solutions to over 14 million people from a global network of 21 manufacturing centers; this includes one molybdenum facility, three large single-photon emission computed tomography (SPECT) facilities, and close to 40 SPECT and positron emission tomography (PET) radiopharmacies.

IBA Molecular acquired the Nuclear Medicine portion of Mallinckrodt in January, completing a process that began in August 2016. The acquisition included Mallinckrodt’s manufacturing operations in the United States and the Netherlands, according to the St. Louis Business Journal.

For more information: www.curiumpharma.com

Related Content

News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Cardiac Imaging

October 6, 2021 – A new study published in Radiology: Cardiothoracic Imaging on cardiac imaging trends over a decade ...

Time October 06, 2021
arrow
News | Magnetic Resonance Imaging (MRI)

September 20, 2021 — Gadolinium-based contrast agents, the gold standard in magnetic resonance imaging (MRI) to ...

Time September 20, 2021
arrow
News | Radiation Oncology

September 17, 2021 — IBA (Ion Beam Applications S.A., EURONEXT), a world leader in particle accelerator technology, and ...

Time September 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Time September 16, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 10, 2021
arrow
News | PET Imaging

September 3, 2021 — Eckert & Ziegler Radiopharma GmbH has successfully submitted an amendment to their Drug Master File ...

Time September 03, 2021
arrow
News | Nuclear Imaging

August 27, 2021 — The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) issued two cooperative ...

Time August 27, 2021
arrow
News | ASTRO

August 11, 2021 — ASTRO announced that it is facilitating measures that seek to ensure optimal health and sanitary ...

Time August 11, 2021
arrow
Subscribe Now